SCHEDULE 13G/A: Janus Henderson Group Discloses 10.0% Stake in ICU Medical, Inc.

Janus Henderson Group PLC has filed an amended Schedule 13G, revealing a beneficial ownership of 10.0% of ICU Medical, Inc.'s common stock as of April 30, 2025.

Summary

• Janus Henderson Group PLC, a Jersey-based parent holding company and investment adviser, reported beneficial ownership of 2,468,086 shares of ICU Medical, Inc. common stock.
• This represents a 10.0% stake in ICU Medical, Inc.'s common stock.
• Janus Henderson Enterprise Fund, a Massachusetts-based investment company, separately reported beneficial ownership of 1,230,753 shares, representing a 5.0% stake.
• Both reporting entities hold shared voting and shared dispositive power over their respective reported shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of ICU Medical, Inc.
• This filing is Amendment No. 10 to the Schedule 13G.

Sentiment

Score: 7

Explanation: The filing indicates a substantial institutional stake by Janus Henderson Group PLC in ICU Medical, Inc., which can be viewed positively as a vote of confidence from a major investment firm. However, the document is purely an ownership disclosure and does not contain performance-related information.

Positives

• The disclosure of a 10.0% beneficial ownership by Janus Henderson Group PLC, a prominent institutional investor, signals significant confidence in ICU Medical, Inc.
• The stated purpose of the investment is for ordinary course of business, indicating a passive, long-term investment strategy rather than an activist stance.

Negatives

• This Schedule 13G filing does not contain any information regarding negative financial performance or operational issues for ICU Medical, Inc.

Risks

• The document does not detail specific operational or financial risks pertaining to ICU Medical, Inc. It only states that the investment is not for the purpose of changing or influencing control of the issuer.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

This filing indicates continued or significant institutional interest in ICU Medical, Inc., a company likely operating in the medical device or healthcare sector. Such disclosures are common for publicly traded companies as large investment firms manage their portfolios.

Stakeholder Impact

• Shareholders: The significant institutional ownership by Janus Henderson Group PLC may enhance investor confidence and potentially contribute to stock stability.
• Management: The passive nature of the investment, explicitly stating it's not for control, suggests that the current management of ICU Medical, Inc. is not facing immediate pressure from this specific shareholder.

Key Dates

Keywords

ICU Medical Inc., Janus Henderson Group PLC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Investment Adviser, Medical Devices, Healthcare